Caspase-3-dependent and caspase-3-independent pathways leading to chromatin DNA fragmentation in HL-60 cells

Apoptosis

Volumn 5, Issue 1, 2000, Pages 61-67

  Meng, X W ^a,c   Fraser, M J ^a,b   Feller, J M ^a   Ziegler, J B ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c MAYO CLINIC   (United States)

Author keywords

Apoptosis; Caspase; Etoposide; Hydroxychloroquine; Nuclease

Indexed keywords

AURINTRICARBOXYLIC ACID; CASPASE 3; CASPASE INHIBITOR; DNA FRAGMENT; ENDONUCLEASE; ETOPOSIDE; HYDROXYCHLOROQUINE;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CHROMATIN; CONTROLLED STUDY; DNA DEGRADATION; DRUG EFFECT; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AURINTRICARBOXYLIC ACID; CASPASE 3; CASPASES; CELL NUCLEUS; CHROMATIN; DNA FRAGMENTATION; ETOPOSIDE; HL-60 CELLS; HUMANS; HYDROXYCHLOROQUINE; OLIGOPEPTIDES; PROTEINS; SUBCELLULAR FRACTIONS;

EID: 0034101492     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009689710184     Document Type: Article

References (30)

1. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1-16.
2. Enari M, Sakahira H, Yokoyama K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis. Nature 1998; 391: 43-50.
3. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998: 391; 96-99.
4. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175-184.
5. Liu X, Li P, Widlak P, Zou H, Luo X, Garrard WT, Wang X. The 40-kDA subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis, Proc Natl Acad Sci USA 1998; 95: 8461-8466.
6. Mukae N, Enari M, Sakahira H, et al. Molecular cloning and characterization of human caspase-activated DNase. Proc Natl Acad Sci USA 1998; 95; 9123-9128.
7. Zamzami N, Susin S, Marchetti P, et al. Mitochondrial control of nuclear apoptosis. J Exp Med 1996; 183: 1533-1544.
8. Susin S, Zamzami N, Castedo M, et al. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med 1997; 186: 25-37.
9. Susin S, Lorenzo HK, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999; 189: 381-394.
10. Krippner A, Matsuno-Yagi A, Gottlieb RA, Babior BM. Loss of function of cytochrome c in Jurkat cells undergoing Fas-mediated apoptosis. J Biol Chem 1996; 271: 21629-21636.
11. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 89: 175-184.
12. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-11136.
13. Kluck RM, Martin SJ, Hoffman BM, Zhou JS, Green DR, Newmeyer DD. Cytochrome c activation of CPP-32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J 1997; 16: 4639-4649.
14. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1126-1132.
15. Marzo I, Brenner C, Zamzami N, Susin S, et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2-related proteins. J Exp Med 1998; 187: 1261-1271.
16. Zanzami N, Marchetti P, Castedo M, et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995; 181: 1661-1672.
17. Meng XW, Fraser MJ, Ireland CM, Feller JM, Ziegler JB. An investigation of a possible role for mitochondrial nuclease in apoptosis. Apoptosis 1998; 3: 395-406.
18. Scaffidi C, Fuida S, Srinivasan A, et al. Two CD95 (APO-a/Fas) signaling pathways. EMBO J 1998; 17: 1675-1687.
19. Adjei PN, Kaufmann SH, Leung, et al. Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathwway that does not activate cysteine protease P32. J Clinic Invest 1996; 98: 2588-2596.
20. Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GC. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by Z-VAD-fmk. J Cell Biol 1998; 140: 637-645.
21. Monney L, Otter I, Olivier R, et al. Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J Biol Chem 1998; 273: 6121-6131.
22. Saeki K, Akira Y, Kato M, Miyazono K, Yakazaki Y, Takaku F. Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown factor, is inhibited by transforming growth factor beta 1 and overexpression of Bcl-2. J Biol Chem 1997; 272: 20003-20010.
23. Martins LM, Kottke TJ, Messner PW, et al. Activation of multiple interleukin-1beta converting homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J Biol Chem 1997; 272: 7421-7430.
24. McConkey DJ, Hartzell P, Nicotera P, et al. Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J 1989; 3: 1843-1849.
25. Fraser MJ, Low RL. Fungal and mitochondrial nucleases. In: Roberts RJ, Linn SM, Lloyd RS, eds. Nucleases, Second Edition. Cold Spring Harbor Laboratory Press 1993: 171-207.
26. Fraser MJ, Tynan SJ, Papaioannou A, Ireland CM, Pittman SM. Endo-exonuclease of human leukaemic cells: evidence for a role in apoptosis. J Cell Sci 1996; 109: 2343-2360.
27. Martins LM, Messner PW, Kottke TJ, et al. Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 1998; 90: 4283-4296.
28. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J, et al. The CED-3/interleukin-1β-converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2 are substrates for the apoptotic mediator CPP32. J Biol Chem 1996; 271: 27099-27106.
29. Zvaifler NJ. The subcellular localization of chloroquine and its effect on lysosomal disruption. Arthritis Rheum 1964; 7: 760-761.
30. Poole B, Ohkuma S. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol 1981; 90: 665-669.